EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Encapsulated papillary carcinoma of the breast: An institutional case series and literature review

Hiang Jin Tan iD, Puay Hoon Tan, Lester Chee Hao Leong, Veronique Kiak Mien Tan, Benita Kiat Tee Tan, Sue Zann Lim, Madhukumar Preetha, Chow Yin Wong, Wei Sean Yong, Yirong Sim

Cancer Medicine · 2023

DOI: 10.1002/cam4.5855 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Medicine, 2023. Verfasst von Hiang Jin Tan und 9 weiteren Autor:innen. Beteiligte Einrichtung: SingHealth Duke-NUS Breast Centre, Singapore, Singapore. Hauptthemen laut MEDLINE: Carcinoma, Papillary, Carcinoma in Situ, Carcinoma, Intraductal, Noninfiltrating, Breast Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Encapsulated papillary carcinoma of the breast is rare, making difficult diagnosis and resulting in patients undergoing excision biopsy before definitive surgery. Evidence‐based guidelines are sparse. We would like to further elucidate the clinicopathological, treatment and survival outcomes. Materials and Methods 54 patients identified, with a median follow up duration of 48 months. Patients' demographics, radiological and clinicopathological characteristics, treatment, adjuvant therapies as well as survival data were analysed.

Results

18 (33.3%) cases were pure EPC, 12 (22.2%) were EPC associated with ductal carcinoma in situ (DCIS) and 24 (44.4%) cases had concurrent invasive ductal carcinoma. EPCs were more likely to present as a solid‐cystic mass on sonography (63.8%), regular‐shaped (oval or round) (97.9%), lack spiculations (95.7%) and lack suspicious microcalcifications (95.6%). Median tumour size was largest in the EPC with IDC group (18.5 mm). 2 patients developed loco‐regional recurrence. Overall survival is good for EPCs of all subtypes.

Conclusion

EPC is a rare tumour with excellent prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, PapillaryCarcinoma in SituCarcinoma, Intraductal, NoninfiltratingBreast NeoplasmsCarcinoma, Ductal, BreastHumansFemaleBreastPrognosisRetrospective Studies

Stichwörter der Autor:innen

breastencapsulatedpapillary

Autor:innen und Institutionen

  • SingHealth Duke-NUS Breast Centre, Singapore, Singapore.
  • Department of Breast Surgery, Singapore General Hospital, Singapore, Singapore.
  • Division of Pathology, Singapore General Hospital, Singapore, Singapore.
  • Duke-NUS Medical School, Singapore, Singapore.
  • Department of Diagnostic Radiology, Singapore General Hospital, Singapore, Singapore.
  • Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.

ORCID-Profile: Hiang Jin Tan

Zitieren

APA

Tan, H. J., Tan, P. H., Leong, L. C. H., Tan, V. K. M., Tan, B. K. T., Lim, S. Z., Preetha, M., Wong, C. Y., Yong, W. S., & Sim, Y. (2023). Encapsulated papillary carcinoma of the breast: An institutional case series and literature review. Cancer Medicine. https://doi.org/10.1002/cam4.5855

Vancouver

Tan HJ, Tan PH, Leong LCH, Tan VKM, Tan BKT, Lim SZ, et al. Encapsulated papillary carcinoma of the breast: An institutional case series and literature review. Cancer Medicine. 2023. doi:10.1002/cam4.5855

BibTeX
@article{Tan2023,
  author = {Tan, Hiang Jin and Tan, Puay Hoon and Leong, Lester Chee Hao and Tan, Veronique Kiak Mien and Tan, Benita Kiat Tee and Lim, Sue Zann and Preetha, Madhukumar and Wong, Chow Yin and Yong, Wei Sean and Sim, Yirong},
  title = {Encapsulated papillary carcinoma of the breast: An institutional case series and literature review},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.5855}
}
Kostenlos starten →